For: | Mattos ÂZ, Debes JD, Dhanasekaran R, Benhammou JN, Arrese M, Patrício ALV, Zilio AC, Mattos AA. Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge. World J Hepatol 2021; 13(9): 1107-1121 [PMID: PMC8473502 DOI: 10.4254/wjh.v13.i9.1107] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i9/1107.htm |
Number | Citing Articles |
1 |
Cristiane Valle Tovo, Angelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana D P Sartori, Livia Villela Nogueira, Gustavo Tovo Both, Cristiane A Villela-Nogueira, Angelo A de Mattos. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. World Journal of Gastroenterology 2023; 29(2): 343-356 doi: 10.3748/wjg.v29.i2.343
|
2 |
Angelo Zambam de Mattos, Isadora Zanotelli Bombassaro, Arndt Vogel, Jose D Debes. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice. World Journal of Gastroenterology 2024; 30(19): 2488-2495 doi: 10.3748/wjg.v30.i19.2488
|
3 |
Marina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, Domingo Balderramo, Enrique Carrera, Jose D. Debes. Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network. Annals of Hepatology 2023; 28(2): 100876 doi: 10.1016/j.aohep.2022.100876
|
4 |
Hua-Dong Li, Ya-Nan Liu, Shuang Wu, Xu-Feng Quan, Xiao-Yan Wang, Tian-Dan Xiang, Shu-Meng Li, Ling Xu, Tong Wang, Hua Wang, Xin Zheng. Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus. World Journal of Hepatology 2024; 16(12): 1395-1406 doi: 10.4254/wjh.v16.i12.1395
Abstract(159) |
Core Tip(166) |
Full Article(HTML)(566)
|
Full Article with Cover (PDF)-1678K(28)
|
Audio-949K(4)
|
Peer-Review Report-183K(19)
|
Answering Reviewers-157K(21)
|
Supplementary Material-219K(18)
|
Full Article (PDF)-1477K(43)
|
Full Article (XML)-127K(19)
|
Times Cited (0)
|
Total Visits (1611)
|
Open
|
5 |
Jie‐Lun Ku, Jia‐Rou Hsu, Yung‐Tsung Li, Li‐Ling Wu. Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review. Journal of Gastroenterology and Hepatology 2025; 40(1): 33 doi: 10.1111/jgh.16750
|
6 |
Avilene Rodríguez-Lara, Ascensión Rueda-Robles, María José Sáez-Lara, Julio Plaza-Diaz, Ana I. Álvarez-Mercado. From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players. Pathogens 2023; 12(7): 940 doi: 10.3390/pathogens12070940
|
7 |
Ioana Rusu, Radu Pirlog, Paul Chiroi, Andreea Nutu, Vlad Radu Puia, Alin Cornel Fetti, Daniel Radu Rusu, Ioana Berindan-Neagoe, Nadim Al Hajjar. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. International Journal of Molecular Sciences 2022; 23(20): 12370 doi: 10.3390/ijms232012370
|
8 |
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, Bithin Kumar Maji. Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis. International Immunopharmacology 2024; 133: 112091 doi: 10.1016/j.intimp.2024.112091
|